The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes of patients with HER2-positive microinvasive breast cancer.
 
Yeokyeong Shin
No Relationships to Disclose
 
Soo-Young Lee
No Relationships to Disclose
 
Hyehyun Jeong
No Relationships to Disclose
 
Hee Jin Lee
No Relationships to Disclose
 
Gyungyub Gong
No Relationships to Disclose
 
Hee Jeong Kim
Honoraria - Alvogen Korea; Takeda
 
Jong Won Lee
No Relationships to Disclose
 
Byung-Ho Son
No Relationships to Disclose
 
BeomSeok Ko
No Relationships to Disclose
 
Jisun Kim
No Relationships to Disclose
 
Jin-Hee Ahn
No Relationships to Disclose
 
Kyung Hae Jung
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Bixink; Celgene; Daiichi Sankyo/Astra Zeneca; Eisai; Eisai; Everest Medicine; Merck; MSD; Novartis; Novartis; Pfizer; Roche; Takeda
 
Sung-Bae Kim
Stock and Other Ownership Interests - Genopeaks
Honoraria - DAEHWA Pharmaceutical; Kalbe Farma; LegoChem Biosciences
Consulting or Advisory Role - AstraZeneca; BeiGene; DAEHWA Pharmaceutical; Daiichi Sankyo/Astra Zeneca; Ensol Biosciences; ISU Abxis; Lilly (Inst); OBI Pharma
Research Funding - Genzyme (Inst)
 
Sae Byul Lee
No Relationships to Disclose
 
Jae Ho Jeong
No Relationships to Disclose